The cholinesterase inhibitor donepezil (Aricept) failed to improve multiple sclerosis patients' memory impairments in a placebo-controlled trial, researchers said.
As many as three out of four women have uterine fibroids sometime during their lives, and for some uterine fibroids can be quite painful. Over the past several years there have been many advancements in treatment options available to women. … Continue reading →
Over the last four years, otolaryngologists at the Mayo Clinic have gained extensive experience using robotic surgery to remove tumors of the tonsils and base of the tongue. In a recent study, a team of head and neck surgeons investigated … Continue reading →
Getting a handle on bipolar disorder is like riding a roller coaster with both patients and physicians — all hollering for stability. There is no diagnostic test to confirm bipolar disorder, and choosing the optimal drug therapy is a frustrating … Continue reading →
Clinicians treating multiple sclerosis are facing a significant challenge as patients start to clamor for treatments based on an as yet unproven vascular theory of the disease, according to a prominent MS researcher in this exclusive ALLMedPage Today interview.
As expected, the FDA has approved new label language for the multiple sclerosis drug natalizumab (Tysabri) with additional detail on the risks of progressive multifocal leukoencephalopathy (PML).
Why multiple sclerosis strikes women more often than men remains unclear, but, as a well-known neurologist explains in this exclusive ALLMedPage Today interview, risk factors including MHC genotype are providing new clues to the disease process.
Minnesota Governor Mark Dayton recently proclaimed the week of April 18-22, 2011, as Music Therapy Week. This exciting news supports the effectiveness of Music Therapy in the healthcare setting. Christina Ufer, Music Therapist-Board Certified, uses live music interventions with pediatric … Continue reading →
Chronic cerebrospinal venous insufficiency is increased in prevalence among patients with multiple sclerosis but is unlikely to play a primary causative role in the disease, a large study suggested.
The FDA has approved a new device for patients suffering from large, giant and wide-necked cerebral aneurysms. Mayo Clinic is one of two centers in the country using the technology. In this blog post, Mayo Clinic neurosurgeon Guiseppe Lanzino, M.D., … Continue reading →
Patients with atrial fibrillation are more likely to develop non-amnestic mild cognitive impairment (MCI) report researchers from the Mayo Clinic. Moreover, women with atrial fibrillation are more likely than men to develop the condition. This study was presented at the … Continue reading →